市场调查报告书
商品编码
1603841
到 2030 年功能性内视镜鼻窦手术的市场预测:按产品类型、手术、患者类型、应用、最终用户和地区进行全球分析Functional Endoscopic Sinus Surgery Market Forecasts to 2030 - Global Analysis By Product Type, Procedure, Patient Type, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球功能性内视镜鼻窦手术市场规模为 34.1 亿美元,预测期内复合年增长率为 11.6%,预计到 2030 年将达到 65.9 亿美元。
一种称为功能性内视镜鼻窦手术(FESS)的微创手术使用内视镜改善鼻窦通气和功能,以治疗慢性鼻窦炎和其他鼻窦相关疾病。为了恢復正常气流,必须清除息肉或感染组织等阻塞物。在手术过程中,医生使用内视镜(带有摄影机的细管)进入鼻窦并清除黏液或异常生长物等阻塞物。 FESS 改善鼻窦通气和引流,减少发炎并缓解症状。当其他治疗方法(例如药物)无法解决鼻窦问题时,通常会建议这样做。
根据美国疾病管制与预防中心 ( 美国) 的数据,美国有超过 2,800 万名成年人被诊断出患有鼻窦炎。大约 11.6% 的美国成年人患有这种疾病。根据美国生物技术资讯中心的数据,2015年,美国约有6%至13%的儿童在3岁时患有慢性鼻窦炎或急性鼻窦炎。
人们对鼻窦疾病的认识不断提高
随着越来越多的人意识到鼻窦疾病以及越来越多的人接受诊断和治疗,功能性内视镜鼻窦手术(FESS) 市场受到了重大影响。倡议和医疗保健组织正在进行宣传活动,教育人们了解慢性鼻窦炎的症状和后果,并敦促他们咨询医生。这种认识的提高将改善患者治疗鼻窦相关疾病的结果,促进 FESS 作为一种有效的治疗方法,并鼓励早期疗育。
农村地区意识淡薄
在农村地区,缺乏对功能性内视镜鼻窦手术(FESS) 的了解会对患者的治疗结果和服务可近性产生负面影响。由于许多人仍然不知道该手术的好处和可近性,因此与鼻窦相关的疾病仍未被诊断和治疗。这种无知增加了慢性鼻窦炎的盛行率及其相关后果。这增加了这些人群的整体健康负担,并加剧了现有的医疗保健不平等。
改善医疗保健服务的获取
透过改善医疗服务的可近性,可以实现鼻窦相关疾病的早期治疗,从而推动功能性内视镜鼻窦手术(FESS) 市场的发展。医疗基础设施的改善意味着更多的患者可以获得专科护理,特别是在服务不足和农村地区。门诊手术中心 (ASC) 和耳鼻喉科专科中心的发展使得门诊手术速度更快,减少了等待时间并改善了患者的治疗效果。除了增加对 FESS 的了解之外,这种改善的获取方式还将促进早期疗育,并最终提高患者满意度和医疗保健。
外科医生短缺且缺乏专业知识
由于缺乏熟练的外科医生,功能性内视镜鼻窦手术(FESS) 领域的患者照护受到严重阻碍。在许多地区,特别是农村地区,缺乏训练有素的耳鼻喉科医生,导致手术等待时间较长,慢性鼻窦炎的治疗方案不足。熟练外科医生的短缺导致手术成功率参差不齐,不仅会延误重要的手术治疗,还会影响患者的整体治疗结果。因此,这种知识的缺乏限制了 FESS 市场的扩张潜力,并加剧了医疗保健不平等。
COVID-19 的影响
功能性内视镜鼻窦手术(FESS) 市场受到 COVID-19 大流行的严重影响,导致常规临床实践和择期手术发生重大中断。由于许多医疗机构优先考虑 COVID-19 患者,因此 FESS 等非紧急手术被推迟。患者无法及时治疗,导致病情恶化,包括慢性鼻窦炎。此外,向远端医疗的转变减少了亲自就诊的次数,使患者难以了解手术选择并接受手术。
预计手术器械产业在预测期内将是最大的。
手术器械部分估计是最大的。技术的发展和对微创手术不断增长的需求正在推动 FESS 市场的手术器械领域。工具设计精确度和人体工学的改进可带来更好的手术效果和更快的患者復原时间。慢性鼻窦炎发生率的增加和门诊手术需求的增加进一步增加了对专业手术设备的需求。此外,内视镜鼻窦手术在新兴国家的普及正在为设备製造商创造新的商机。
预计专科诊所产业在预测期内复合年增长率最高
预计专科诊所领域在预测期内的复合年增长率最高。这些诊所提供有关鼻窦问题的专业治疗和知识,吸引了寻求尖端治疗方法的人。我们经常使用尖端技术和熟练的外科医生为我们的患者提供最好的结果。专科诊所也透过专注于复杂病例、翻修手术和专门手术来满足有特殊需求的患者。专科诊所透过提供个人化治疗和尖端治疗技术,为 FESS 产业的扩张做出贡献。
由于生活方式的改变和都市区污染的增加导致鼻窦相关疾病的增加,预计亚太地区在预测期内将占据最大的市场占有率。由于尖端医疗技术的进步和医疗保健基础设施的扩大,FESS 手术现在得到了更广泛的应用。需求也受到不断增长的中产阶级对鼻窦治疗方案更了解的影响。中国、日本和印度等国家的政府医疗计划和合格的耳鼻喉科医师进一步促进了 FESS 在该地区的使用。
由于引起慢性鼻窦炎及相关疾病的过敏和环境因素的高发生率,预计北美在预测期内将呈现最高的复合年增长率。医疗保健侧重于复杂的医疗系统和微创手术方法。最近的技术进步,例如更好的导航和成像系统,正在改善手术结果并吸引更多患者。此外,由于良好的保险覆盖范围、报销规定以及对鼻窦健康的普遍认识,FESS 手术在整个全部区域变得越来越广泛和受到青睐。
According to Stratistics MRC, the Global Functional Endoscopic Sinus Surgery Market is accounted for $3.41 billion in 2024 and is expected to reach $6.59 billion by 2030 growing at a CAGR of 11.6% during the forecast period. A minimally invasive procedure called functional endoscopic sinus surgery (FESS) uses endoscopic procedures to improve sinus outflow and function in order to treat chronic sinusitis and other sinus-related diseases. To return the airflow to normal, obstructions like polyps or infected tissue must be removed. The surgery involves using an endoscope, a thin tube with a camera, to access and remove blockages, such as mucus or abnormal growths, from the sinuses. FESS improves airflow and drainage in the sinuses, reducing inflammation and relieving symptoms. It is typically recommended when other treatments, such as medication, have not been effective in managing sinus issues.
According to the Centers for Disease Control and Prevention (CDC), over 28 million adults in the U.S. have been diagnosed with sinusitis. This condition affects about 11.6% of all adults in the country. According to the National Center for Biotechnology Information, in 2015, in the U.S., about 6 to 13% of children developed chronic rhinosinusitis and acute rhinosinusitis by the age of 3 years.
Growing awareness of sinus disorders
As more people become aware of sinus conditions, the market for functional endoscopic sinus surgery (FESS) is greatly impacted since more people are being diagnosed and treated. Campaigns to educate people about the signs and consequences of chronic sinusitis are run by advocacy organizations and healthcare organizations, encouraging people to consult a doctor. This increased awareness improves patient outcomes in managing sinus-associated illnesses and promotes FESS as an effective treatment option and encourages earlier intervention, which in turn drives demand for surgical treatments and related healthcare services.
Limited awareness in rural areas
In rural locations, a lack of knowledge about functional endoscopic sinus surgery (FESS) has a detrimental effect on patient outcomes and service accessibility. Many people are still unaware of the advantages and accessibility of this technique, which causes sinus-related disorders to go undiagnosed and untreated. Patients may turn to useless home remedies or forego seeking medical attention entirely as a result of this ignorance, which raises the prevalence of chronic sinusitis and its related consequences. As a result, these groups' general health burden rises, escalating already-existing healthcare inequities.
Improved access to healthcare services
Timely treatment of sinus-related illnesses is made possible by improved access to healthcare services, which in turn boosts the market for functional endoscopic sinus surgery (FESS). More patients can access specialist care as healthcare infrastructure grows, especially in underserved and rural areas. Faster, outpatient operations are made possible by the growth of ambulatory surgery centers (ASCs) and ENT specialist centers, which lower wait times and enhance patient outcomes. In addition to increasing knowledge of FESS, this improved accessibility promotes early intervention, which eventually improves patient satisfaction and health management.
Shortage of surgeon availability and expertise
Patient care in the functional endoscopic sinus surgery (FESS) sector is severely hampered by the lack of available and skilled surgeons. There is a shortage of trained ENT doctors in many places, especially rural ones, which results in lengthy procedure wait times and insufficient alternatives for treating chronic sinusitis. Due to a lack of skilled surgeons, surgical success rates may vary, which affects overall patient outcomes in addition to delaying critical surgical treatments. As a result, this lack of knowledge limits the FESS market's potential for expansion and makes healthcare inequities worsen.
Covid-19 Impact
The functional endoscopic sinus surgery (FESS) market was significantly impacted by the COVID-19 pandemic, which caused major interruptions in routine care and elective surgeries. Numerous medical facilities put COVID-19 patients first, which caused non-urgent operations, like FESS, to be postponed. Patients were unable to receive prompt treatment, which made diseases like chronic sinusitis worse. Furthermore, the move to telemedicine reduced in-person consultations, which made it more difficult for patients to learn about and obtain surgical choices.
The surgical instruments segment is expected to be the largest during the forecast period
The surgical instruments segment is estimated to be the largest. Technological developments and rising demand for minimally invasive procedures are driving the surgical instruments section of the FESS market. Improved precision and ergonomics in tool design lead to better surgical results and shorter recovery times for patients. The need for specialized surgical equipment is being further fuelled by the increasing frequency of chronic sinusitis and the growing desire for outpatient operations. Additionally, new opportunities are being created for instrument producers by the growing use of endoscopic sinus surgery in emerging economies.
The specialty clinics segment is expected to have the highest CAGR during the forecast period
The specialty clinics segment is anticipated to witness the highest CAGR during the forecast period. These clinics draw individuals looking for cutting-edge treatment choices because they provide specialized care and knowledge in sinus issues. To achieve the best possible results for their patients, they frequently use cutting-edge technologies and skilled surgeons. Specialty clinics also serve patients with particular requirements by concentrating on complicated cases, revision surgeries, and specialist procedures. Specialty clinics help the FESS industry expand by providing individualized care and cutting-edge treatment techniques.
Asia Pacific is expected to have the largest market share during the forecast period due to an increase in sinus-related disorders as a result of changing lifestyles and growing urban pollution. FESS operations are now more widely available because to advances in cutting-edge medical technology and expanding healthcare infrastructure. Demand is also influenced by a growing middle class that is more knowledgeable about sinus treatment choices. The use of FESS in the region is further fuelled by government healthcare programs and the availability of qualified ENT doctors in nations like China, Japan, and India.
North America is projected to witness the highest CAGR over the forecast period, owing to a high incidence of allergies and environmental factors contributing to chronic sinusitis and related conditions. Adoption is aided by a sophisticated healthcare system and a focus on minimally invasive surgical methods. Recent advances in technology, such as better navigation and imaging systems, improve surgical results and draw in more patients. Furthermore, FESS operations are more widely available and well-liked throughout the region due to excellent insurance coverage, reimbursement regulations, and general awareness of sinus health.
Key players in the market
Some of the key players profiled in the Functional Endoscopic Sinus Surgery Market include Medtronic plc, Stryker Corporation, Karl Storz SE & Co. KG, Olympus Corporation, Richard Wolf GmbH, Smith & Nephew plc, MediNatura, Inc., Holo Surgical, Inc., Conmed Corporation, B. Braun Melsungen AG, Cerebrospinal Fluid Technologies, Inc, Sino Medical Sciences Technology Inc, KARL STORZ Endoscopy-America, Inc., XION GmbH, Merck KGaA, Aesculap, Inc., Rudolf Medical GmbH, and Cavalier Surgical, LLC.
In June 2024, Olympus introduced its new 4K UHD endoscope system, which provides superior imaging quality and enhanced visualization for complex sinus surgeries, aiming to improve surgical outcomes and patient safety.
In August 2023, Medtronic announced the launch of its new ENT navigation system, designed to enhance the accuracy and efficiency of sinus surgeries by providing real-time, high-definition imaging and guidance.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.